Active Ingredient: FLUDEOXYGLUCOSE F-18
Proprietary Name: FLUDEOXYGLUCOSE F18
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 20-300mCi/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203246
Product Number: 002
Approval Date: Jan 13, 2014
Applicant Holder Full Name: UNIV TEXAS MD ANDERSON CANCER CENTER
Marketing Status:
Prescription
Patent and Exclusivity Information
